ANGO analyst estimates
AngioDynamics (ANGO) analyst ratings, the average price target and its range, and every firm's latest call.
ANGO analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 13, 2026 | H.C. Wainwright | AngioDynamics price target lowered to $18 from $19 at H.C. Wainwright | $18.00 |
| Jul 15, 2026 | Canaccord Genuity | AngioDynamics price target raised to $20 from $16 at Canaccord | $20.00 |
| Jul 15, 2026 | H.C. Wainwright | AngioDynamics price target raised to $19 from $16 at H.C. Wainwright | $19.00 |
| Oct 3, 2025 | Canaccord Genuity | AngioDynamics price target raised to $18 from $17 at Canaccord | $18.00 |
| Jul 16, 2025 | Canaccord Genuity | AngioDynamics price target raised to $17 from $15 at Canaccord | $17.00 |
| Oct 4, 2024 | Canaccord Genuity | AngioDynamics (ANGO) PT Lowered to $12 at Canaccord Genuity | $12.00 |
| Sep 20, 2024 | H.C. Wainwright | H.C. Wainwright Reiterates Buy Rating on AngioDynamics (ANGO) | $14.00 |
| Apr 5, 2024 | Oppenheimer | AngioDynamics upgraded to Outperform from Perform at Oppenheimer | $12.00 |
| Jan 6, 2023 | Raymond James | Raymond James Maintains Strong Buy on AngioDynamics, Lowers Price Target to $22 | $22.00 |
| Jul 13, 2022 | Raymond James | Raymond James Maintains Strong Buy on AngioDynamics, Lowers Price Target to $27 | $27.00 |
- 3 firms rate ANGO: 3 buy, 0 hold, 0 sell.
- The average price target is $19.00 from 2 analysts, from $18.00 to $20.00.
Updated 2026-11-05 12:48 UTC